ASX/RNV (ASX/RNV)

Australian Securities Exchange: ASX/RNV · AUD

A$0.09

+0.00 (0.0%)· Recorded snapshot

Market cap	15.5M
Revenue (ttm)	510.4K
Net income (ttm)	-5.6M
EPS (ttm)	-A$0.04
Shares out	172.3M
Volume	30,000

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 510.4K
Net income (ttm): -5.6M
EPS (ttm): -A$0.04
Market cap: 15.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-133.1

P25 -108P50 -50.6P75 1.1

ROIC-95

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/RNV indicators

Market & fundamental data

Available fields

154

Groups with data

Currency

AUD

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-02
Enterprise value	AUD 14.2M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2016
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000358616
Last earnings date	2026-03-04
Last refreshed	2026-10-30
Market cap	AUD 15.5M
Next earnings date	2026-11-02
Price	AUD 0.09
Price currency	AUD
Sector	Healthcare
SIC code	3842
Stock price date	2026-10-28
Symbol	asx/RNV
Website	https://renerve.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-38.93%
EV/Sales	27.86x
FCF / EV yield	-41.3%
FCF yield	-37.88%
Industry forward P/E	28.82x
P/B ratio	4.88x
P/S ratio	30.38x
Price / tangible book value	5.01x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	53.16%
Operating margin	-1,276.81%
Pretax margin	-1,091.87%
ROA	-75.92%
ROCE	-203.54%
ROE	-133.13%
ROIC	-95.01%
SBC / revenue	123.71%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	10.9%
Gross profit growth (Q)	57.59%
Revenue growth	87.83%
Revenue growth (Q)	104.52%
Revenue growth (QoQ)	111.73%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -73,671
Depreciation and amortization	AUD 30,473
EBIT	AUD -6.5M
EBITDA	AUD -6.5M
EPS	AUD -0.04
FCF per share	AUD -0.03
Financing cash flow	AUD 2.8M
Free cash flow	AUD -5.9M
Free cash flow minus SBC	AUD -6.5M
Gross profit	AUD 271,324
Investing cash flow	AUD -147,381
Net borrowing	AUD -158,490
Net cash flow	AUD -3.3M
Net income	AUD -5.6M
Operating cash flow minus SBC	AUD -6.4M
Operating income	AUD -6.5M
Revenue	AUD 510,357
Stock-based compensation	AUD 631,359

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-2.06
Book value per share	AUD 0.02
Debt / equity	0.06
Interest coverage	-586.58
Long-term assets	AUD 368,619
Long-term liabilities	AUD 25,260
Net cash (debt)	AUD 1.3M
Net cash / market cap	8.3%
Net cash growth	-72.94%
Net debt / equity	-0.41
Piotroski F-Score	1
Property, plant and equipment	AUD 229,434
Shareholders' equity	AUD 3.2M
Tangible book value	AUD 3.1M
Tangible book value per share	AUD 0.02
Total assets	AUD 4.5M
Total cash	AUD 1.5M
Total debt	AUD 201,554
Total liabilities	AUD 1.4M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.1
Current assets	AUD 4.2M
Current liabilities	AUD 1.3M
Current ratio	3.13
Inventory turnover	1.76
Net working capital	AUD 1.5M
Quick ratio	2.35
Working capital	AUD 2.8M
Working capital turnover	0.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-28.95%
Shareholder yield	-28.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.09
1D price change	0%
1M price change	21.62%
1M total return	21.62%
1W price change	5.88%
1W total return	5.88%
1Y price change	-21.74%
1Y return CAGR	-21.75%
1Y total return	-21.74%
20-day SMA	AUD 0.08
200-day SMA	AUD 0.09
3M price change	12.5%
3M total return	12.5%
50-day SMA	AUD 0.08
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.22
52-week high date	2025-11-13
52-week low	AUD 0.07
52-week low date	2026-09-10
6M price change	-14.29%
6M total return	-14.29%
All-time high	AUD 0.22
All-time high date	2025-03-28
All-time low	AUD 0.07
All-time low date	2026-08-27
Average true range (ATR)	AUD 0.00
Average volume	105.6K
Beta (1Y)	1.51
Beta (2Y)	1.25
Change from 52-week high	-59.09%
Change from 52-week low	32.35%
Change from all-time high	-59.09%
Change from all-time low	32.35%
Change from open	0%
Day's gap	0%
Dollar volume	AUD 2,700
High price	AUD 0.09
Low price	AUD 0.09
Monthly RSI	39.08
Open price	AUD 0.09
Previous close	AUD 0.09
Price vs 150-day SMA	3.33%
Price vs 20-day SMA	8.96%
Price vs 200-day SMA	-1.96%
Price vs 50-day SMA	15.09%
Relative volume	0.28
RSI	60.61
Sharpe ratio	0.24
Sortino ratio	0.51
Volume	30K
Weekly RSI	53.23
YTD price change	-10%
YTD total return	-10%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	92.8M
Shares change (QoQ)	16.27%
Shares change (YoY)	28.95%
Shares held by insiders	27.02%
Shares held by institutions	8.95%
Shares outstanding	172.3M

Deeper analysis on ASX/RNV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/RNV report

Is a complete ASX/RNV research report available?

No complete published report is available for asx/RNV (ASX/RNV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/RNV (ASX/RNV)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/RNV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/RNV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/RNV

Frequently asked questions